NEWS

« Back to the news

drapeau blanc
Angiochem: On its way to next step, ongoing preparation for Phase 3 study!

Date : 25 Nov 2015 |

Positive Clinical Data from the ongoing Phase 2 to treat Breast Cancer Patients with CNS Metastases, more specifically with Leptomeningeal Carcinomatosis, were announced earlier this week at the 20th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO), in San Antonio, Texas

 

This is a great news for Angiochem, a spin-off company from UQAM launched by Valeo / Aligo.

 

Read the original Press Release

Share the news

OUR PARTNER INSTITUTIONS

Warning
Error
Ok